
Orthopedics market is witnessing high growth rate globally. High incidence of obesity, osteoporosis, osteoarthritis and aging population are some of the key factors driving the market's growth. Osteoporosis is a condition in which bone mineral density (BMD) decreases, leading to increased risk for fracture. Osteoporosis is a genetic disease and is also termed as "silent disease", as no symptoms shown in this disease. Osteoporosis drug refers to a medicine that is used to maintain BMD of 2.5 standard deviations below a patient's expected peak bone mass. BMD decreases with age, therefore aged population is at increased risk for osteoporosis. Based on drug classes, the market has been divided into bisphosphonates, selective estrogen receptor modulators (SERMs), RANK Ligand Inhibitors (denosumab), parathyroid hormone therapy (PTH), calcitonin and others. Osteoporosis is more common in women as compared to men.